These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1699681

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. v-Ha-ras-induced mouse skin papillomas exhibit aberrant expression of keratin K13 as do their 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate -induced analogues.
    Sutter C, Strickland JE, Welty DJ, Yuspa SH, Winter H, Schweizer J.
    Mol Carcinog; 1991; 4(6):467-76. PubMed ID: 1724371
    [Abstract] [Full Text] [Related]

  • 3. Sequential development of aneuploidy, keratin modifications, and gamma-glutamyltransferase expression in mouse skin papillomas.
    Aldaz CM, Conti CJ, Larcher F, Trono D, Roop DR, Chesner J, Whitehead T, Slaga TJ.
    Cancer Res; 1988 Jun 01; 48(11):3253-7. PubMed ID: 2452689
    [Abstract] [Full Text] [Related]

  • 4. Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10.
    Sundberg JP, Erickson AA, Roop DR, Binder RL.
    Cancer Res; 1994 Mar 01; 54(5):1344-51. PubMed ID: 7509717
    [Abstract] [Full Text] [Related]

  • 5. Aberrant expression of the simple epithelial type II keratin 8 by mouse skin carcinomas but not papillomas.
    Larcher F, Bauluz C, Díaz-Guerra M, Quintanilla M, Conti CJ, Ballestín C, Jorcano JL.
    Mol Carcinog; 1992 Mar 01; 6(2):112-21. PubMed ID: 1382441
    [Abstract] [Full Text] [Related]

  • 6. Changes in protein expression during multistage mouse skin carcinogenesis.
    Rundhaug JE, Gimenez-Conti I, Stern MC, Budunova IV, Kiguchi K, Bol DK, Coghlan LG, Conti CJ, DiGiovanni J, Fischer SM, Winberg LD, Slaga TJ.
    Mol Carcinog; 1997 Sep 01; 20(1):125-36. PubMed ID: 9328443
    [Abstract] [Full Text] [Related]

  • 7. Low frequency of codon 61 Ha-ras mutations and lack of keratin 13 expression in 7,12-dimethylbenz[a]-anthracene-induced hamster skin tumors.
    Robles AI, Gimenez-Conti IB, Roop D, Slaga TJ, Conti CJ.
    Mol Carcinog; 1993 Sep 01; 7(2):94-8. PubMed ID: 7681292
    [Abstract] [Full Text] [Related]

  • 8. Tissue-specific expression of murine keratin K13 in internal stratified squamous epithelia and its aberrant expression during two-stage mouse skin carcinogenesis is associated with the methylation state of a distinct CpG site in the remote 5'-flanking region of the gene.
    Winter H, Rentrop M, Nischt R, Schweizer J.
    Differentiation; 1990 Apr 01; 43(2):105-14. PubMed ID: 1695590
    [Abstract] [Full Text] [Related]

  • 9. Aberrant expression during two-stage mouse skin carcinogenesis of a type I 47-kDa keratin, K13, normally associated with terminal differentiation of internal stratified epithelia.
    Nischt R, Roop DR, Mehrel T, Yuspa SH, Rentrop M, Winter H, Schweizer J.
    Mol Carcinog; 1988 Apr 01; 1(2):96-108. PubMed ID: 3076454
    [Abstract] [Full Text] [Related]

  • 10. Aberrant in vitro expression of keratin K13 induced by Ca2+ and vitamin A acid in mouse epidermal cell lines.
    Sutter C, Nischt R, Winter H, Schweizer J.
    Exp Cell Res; 1991 Jul 01; 195(1):183-93. PubMed ID: 1711471
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. ras gene activation and aberrant expression of keratin K13 in ultraviolet B radiation-induced epidermal neoplasias of mouse skin.
    Sutter C, Strickland PT, Mukhtar H, Agarwal R, Winter H, Schweizer J.
    Mol Carcinog; 1993 Jul 01; 8(1):13-9. PubMed ID: 7688967
    [Abstract] [Full Text] [Related]

  • 14. Changes in keratin expression during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.
    Gimenez-Conti IB, Shin DM, Bianchi AB, Roop DR, Hong WK, Conti CJ, Slaga TJ.
    Cancer Res; 1990 Jul 15; 50(14):4441-5. PubMed ID: 1694722
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous appearance of keratin modifications and gamma-glutamyltransferase activity as indicators of tumor progression in mouse skin papillomas.
    Klein-Szanto AJ, Nelson KG, Shah Y, Slaga TJ.
    J Natl Cancer Inst; 1983 Jan 15; 70(1):161-8. PubMed ID: 6185712
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW, Conti CJ, Kruszewski FH, Slaga TJ, DiGiovanni J.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM, Bolon I, Nichols A, Wohlwend A, Vassalli JD.
    Cancer Res; 2001 Feb 01; 61(3):970-6. PubMed ID: 11221892
    [Abstract] [Full Text] [Related]

  • 19. Promoter independence as a feature of most skin papillomas in SENCAR mice.
    Aldaz CM, Conti CJ, Chen A, Bianchi A, Walker SB, DiGiovanni J.
    Cancer Res; 1991 Feb 01; 51(3):1045-50. PubMed ID: 1899044
    [Abstract] [Full Text] [Related]

  • 20. The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis.
    Tennenbaum T, Weiner AK, Belanger AJ, Glick AB, Hennings H, Yuspa SH.
    Cancer Res; 1993 Oct 15; 53(20):4803-10. PubMed ID: 8402665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.